Medical Crossfire: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid Development

Medical Crossfire: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid Development is organized by Physicians Education Resource, LLC (PER) and will be held during Sep 29, 2017 - Sep 29, 2018.

The target audience for this medical event is directed oncologists interested in the treatment of lung cancer. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with lung cancer are also invited to participate. This CME Conference has been approved for a maximum of 1.5 AMA PRA Category 1 Credits.

Conference Overview :
This online activity features an expert panel discussion of key data in lung cancer immunotherapy, including practice-changing data and commentary on the optimal duration of therapy, combination regimens, biomarkers, and the management of immune-related adverse events. Throughout the program, the experts provide their perspectives on the clinical application of these data and the future direction of immunotherapies within the lung cancer treatment landscape.

Conference Objectives :
At the conclusion of this activity, you should be better prepared to:
• Describe the mechanistic rationale for single agent and combination immunotherapeutic strategies in the management of advanced non–small cell lung cancer (NSCLC)
• Evaluate findings from recent trials in the context of evolving immunotherapy treatment paradigms for patients with advanced NSCLC
• Explain emerging perspectives on the use of biomarkers as a method to personalize care with the use of immunotherapeutic strategies
• Apply best practices to proactively manage and mitigate the impact of treatment-related toxicities with the use of evolving immunotherapeutic combination approaches

Additional details will be posted as soon as they are available.